{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:54:33Z","timestamp":1740135273978,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570671","81470964"],"award-info":[{"award-number":["81570671","81470964"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81522010"],"award-info":[{"award-number":["81522010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12882-018-0844-2","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T06:02:59Z","timestamp":1520316179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Case report: lipid inclusion in glomerular endothelial and mesangial cells in a patient after contrast medium injection"],"prefix":"10.1186","volume":"19","author":[{"given":"Hua","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Yan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Xia","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,6]]},"reference":[{"key":"844_CR1","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1038\/sj.ki.5000368","volume":"100","author":"R Mehran","year":"2006","unstructured":"Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl. 2006;100:S11\u20135.","journal-title":"Kidney Int Suppl"},{"key":"844_CR2","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1038\/emm.2014.38","volume":"46","author":"YM Park","year":"2014","unstructured":"Park YM. CD36, a scavenger receptor implicated in atherosclerosis. Exp Mol Med. 2014;46:e99.","journal-title":"Exp Mol Med"},{"key":"844_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/MOL.0000000000000258","volume":"27","author":"JK Bielicki","year":"2016","unstructured":"Bielicki JK. ABCA1 agonist peptides for the treatment of disease. Curr Opin Lipidol. 2016;27:40\u20136.","journal-title":"Curr Opin Lipidol"},{"key":"844_CR4","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1053\/j.ajkd.2006.05.034","volume":"48","author":"ER Bracamonte","year":"2006","unstructured":"Bracamonte ER, Kowalewska J, Starr J, Gitomer J, Alpers CE. Iatrogenic Phospholipidosis mimicking Fabry disease. Am J Kidney Dis. 2006;48:844\u201350.","journal-title":"Am J Kidney Dis"},{"key":"844_CR5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jcrc.2011.05.010","volume":"26","author":"K Lakhal","year":"2011","unstructured":"Lakhal K, Ehrmann S, Chaari A, Laissy JP, R\u00e9gnier B, Wolff M, Pajot O. Acute kidney injury network definition of contrast-induced nephropathy in the critically ill: incidence and outcome. J Crit Care. 2011;26:593\u20139.","journal-title":"J Crit Care"},{"key":"844_CR6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.2215\/CJN.02600607","volume":"3","author":"SN Heyman","year":"2008","unstructured":"Heyman SN, Rosen S, Rosenberger C. Renal parenchymal hypoxia, hypoxia adaptation, and the pathogenesis of radiocontrast nephropathy. Clin J Am Soc Nephrol. 2008;3:288\u201396.","journal-title":"Clin J Am Soc Nephrol"},{"key":"844_CR7","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1440-1681.2011.05503.x","volume":"38","author":"MM Sendeski","year":"2011","unstructured":"Sendeski MM. Pathophysiology of renal tissue damage by iodinated contrast media. Clin Exp Pharmacol Physiol. 2011;38:292\u20139.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"844_CR8","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1148\/radiology.147.3.6844605","volume":"147","author":"C Gospos","year":"1983","unstructured":"Gospos C, Freudenberg N, Staubesand J, Mathias K, Papacharlampos X. The effect of contrast media on the aortic endothelium of rats. Radiology. 1983;147:685\u20138.","journal-title":"Radiology"},{"key":"844_CR9","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.bbrc.2015.03.153","volume":"460","author":"J Janikiewicz","year":"2015","unstructured":"Janikiewicz J, Hanzelka K, Kozinski K, Kolczynska K, Dobrzyn A. Islet \u03b2-cell failure in type 2 diabetes--within the network of toxic lipids. Biochem Biophys Res Commun. 2015;460:491\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"844_CR10","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.amjcard.2014.07.059","volume":"114","author":"A Ukaigwe","year":"2014","unstructured":"Ukaigwe A, Karmacharya P, Mahmood M, Pathak R, Aryal MR, Jalota L, Donato AA. Meta-analysis on efficacy of statins for prevention of contrast-induced acute kidney injury in patients undergoing coronary angiography. Am J Cardiol. 2014;114:1295\u2013302.","journal-title":"Am J Cardiol"},{"key":"844_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/1755-5922.12108","volume":"33","author":"M Shehata","year":"2015","unstructured":"Shehata M, Hamza M. Impact of high loading dose of atorvastatin in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention: a randomized controlled trial. Cardiovasc Ther. 2015;33:35\u201341.","journal-title":"Cardiovasc Ther"},{"key":"844_CR12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jacc.2013.09.017","volume":"63","author":"Y Han","year":"2014","unstructured":"Han Y, Zhu G, Han L, Hou F, Huang W, Liu H, Gan J, Jiang T, Li X, Wang W, Ding S, Jia S, Shen W, Wang D, Sun L, Qiu J, Wang X, Li Y, Deng J, Li J, Xu K, Xu B, Mehran R, Huo Y. Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease. J Am Coll Cardiol. 2014;63:62\u201370.","journal-title":"J Am Coll Cardiol"},{"key":"844_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijcard.2015.01.046","volume":"183","author":"G Marenzi","year":"2015","unstructured":"Marenzi G, Cosentino N, Werba JP, Tedesco CC, Veglia F, Bartorelli AL. A meta-analysis of randomized controlled trials on statins for the prevention of contrast-induced acute kidney injury in patients with and without acute coronary syndromes. Int J Cardiol. 2015;183:47\u201353.","journal-title":"Int J Cardiol"},{"key":"844_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ejphar.2013.10.025","volume":"723","author":"J Su","year":"2014","unstructured":"Su J, Zou W, Cai W, Chen X, Wang F, Li S, Ma W, Cao Y. Atorvastatin ameliorates contrast medium-induced renal tubular cell apoptosis in diabetic rats via suppression of rho-kinase pathway. Eur J Pharmacol. 2014;723:15\u201322.","journal-title":"Eur J Pharmacol"},{"key":"844_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1471-2369-15-14","volume":"15","author":"K Wu","year":"2014","unstructured":"Wu K, Lei W, Tian J, Li H. Atorvastatin treatment attenuates renal injury in an experimental model of ischemia-reperfusion in rats. BMC Nephrol. 2014;15:14.","journal-title":"BMC Nephrol"},{"issue":"17","key":"844_CR16","doi-asserted-by":"publisher","first-page":"539","DOI":"10.5551\/jat.2956","volume":"30","author":"E Mandosi","year":"2010","unstructured":"Mandosi E, Fallarino M, Gatti A, Carnovale A, Rossetti M, Lococo E, Buchetti B, Filetti S, Lenti L, Morano S. Atorvastatin downregulates monocyte CD36 expression, nuclear NF kappaB and TNF alpha levels in type 2 diabetes. J Atheroscler Thromb. 2010;30(17):539\u201345.","journal-title":"J Atheroscler Thromb"},{"key":"844_CR17","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1161\/ATVBAHA.114.303715","volume":"34","author":"T Shimizu","year":"2014","unstructured":"Shimizu T, Miura S, Tanigawa H, Kuwano T, Zhang B, Uehara Y, Saku K. Rosuvastatin activates ATP-binding cassette transporter A1-dependent efflux ex vivo and promotes reverse cholesterol transport in macrophage cells in mice fed a high-fat diet. Arterioscler Thromb Vasc Biol. 2014;34:2246\u201353.","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-0844-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T19:26:25Z","timestamp":1551813985000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-018-0844-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,6]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["844"],"URL":"https:\/\/doi.org\/10.1186\/s12882-018-0844-2","relation":{},"ISSN":["1471-2369"],"issn-type":[{"type":"electronic","value":"1471-2369"}],"subject":[],"published":{"date-parts":[[2018,3,6]]},"assertion":[{"value":"7 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed consent was obtained from each patient for renal biopsy and this study was in compliance with the Declaration of Helsinki and was approved by the local ethical committees. Otherwise, no additional ethical approval was required for this case report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"53"}}